Print

Selling or acquiring a dental practice in Arizona is one of the most significant financial decisions a dentist may ever make, and the margin for error is very small. These transactions carry substantial legal, regulatory, and financial complexity, from practice valuation and asset allocation to employment agreements and state licensure requirements. Getting the terms right at the start can mean the difference between a clean transition and a costly dispute.

The National Dental Law Group at Mandelbaum Barrett PC has handled dental practice transactions across the country, and our attorneys are well-versed in the nuances of Arizona dental M&A. Our team, led by CEO William Barrett and including Partners Casey Gocel and Melody M. Block, brings decades of combined experience to every deal, whether you are an independent dentist, a group practice, or a dental support organization (DSO). 

What Makes Arizona Dental M&A Unique?

Arizona’s dental market has expanded considerably in recent years, driven by significant population growth in Phoenix, Tucson, Scottsdale, and surrounding areas. That growth has attracted increased DSO activity to the state, creating new opportunities for both buyers and sellers. According to data published by the ADA Health Policy Institute, DSO-affiliated practices have grown substantially over the past decade, reshaping how dental practices are structured, bought, and sold nationwide.

For Arizona dentists, this market activity means more potential buyers. In turn, that also means more complex deal structures. Knowing whether a transaction should be structured as an asset sale or a stock sale, how to handle real estate or lease assignments, and what Arizona-specific licensing requirements apply can all drastically affect your outcome. The Arizona State Board of Dental Examiners has its own rules around practice ownership and license transfers, and those requirements must be addressed before or alongside the transaction itself.

Every dental practice transaction involves a range of interconnected legal issues, and how each is handled can have a lasting impact on both parties. Below are the core areas our team addresses in Arizona dental deals.

Practice Valuation and Deal Structure

Determining the fair market value of your practice is the foundation of any successful transaction. Factors such as patient base, revenue trends, staff, equipment, and lease terms all influence valuation. Our team helps you understand how all these factors shape your position and negotiates a deal structure that aligns with your financial goals.

Whether structured as an asset sale or a stock sale has significant tax implications for both parties. Most Arizona dental transactions involve the transfer of specific assets, including goodwill, equipment, patient records, and lease rights, each carrying its own legal and tax treatment. Mandelbaum Barrett PC has helped clients navigate transactions across a wide range of sizes and structures, including multi-state dental acquisitions and complex DSO deals.

DSO Transactions and Equity Components

Selling to a DSO is one of the most common paths for Arizona dentists looking to monetize their practice while remaining clinically active. These deals often include an equity rollover, meaning that you may retain a percentage of ownership in the acquiring organization. Knowing what that equity is worth and what rights you hold as a minority owner requires careful review before signing.

Our attorneys have guided clients through numerous DSO transactions, including deals with equity components totaling over $3.5 million. The four-phase DSO transaction process moves through letter of intent, due diligence, document negotiation, and closing, and each phase presents real opportunities to protect or strengthen your position.

Employment Agreements and Non-Compete Clauses

In most dental practice transactions, the selling dentist will be asked to sign both an employment agreement and a non-compete clause. Arizona courts have enforced reasonable non-compete agreements in professional settings, but the scope, duration, and geographic limits all matter. Having an attorney review and negotiate these terms before you sign may protect your ability to continue practicing in the area if the relationship changes down the road.

Why Work with Mandelbaum Barrett PC?

Our dental law practice brings together attorneys with deep backgrounds in healthcare law, corporate transactions, real estate, and employment law, allowing us to handle every component of a dental transaction under one roof. That cross-disciplinary approach has helped us close deals efficiently and catch issues single-practice firms may overlook. Our resources, including the guide 13 essential steps to purchasing or selling your dental practice, reflect the depth of knowledge our team brings to each engagement.

We do not take a one-size-fits-all approach since every transaction is different. We take the time to understand your goals, timeline, and concerns before advising on strategy. Whether you are a first-time buyer, a retiring seller, or a growing group practice, our attorneys provide clear, practical guidance every step of the way.

Contact Mandelbaum Barrett PC for Arizona Dental M&A

The National Dental Law Group at Mandelbaum Barrett PC has closed dental practice transactions across the country, from solo practice sales to multi-location DSO deals. We have also secured favorable outcomes for dental clients facing litigation, demonstrating our ability to protect dentists at every stage of practice ownership.

When you are ready to take the next step in your Arizona dental practice transaction, contact our office to speak with a member of our team.

This content is for informational purposes only and does not constitute legal advice. Please consult with a qualified attorney regarding your specific situation.

What Aurobindo/Lannett Tells Us About the FTC’s Current Approach to Pharmaceutical M&A

July 20, 2026

Although the Federal Trade Commission (“FTC”) continues to scrutinize mergers involving pharmaceutical companies, recent enforcement suggests that, in some cases, transactions presenting discrete competitive issues may still find a path to clearance through targeted divestitures. The FTC’s recent consent order permitting Aurobindo Pharma’s acquisition of Lannett Company to proceed is the latest example. The decision […]